Latest Breaking News On - Lingshi - Page 13 : vimarsana.com

dMed Completed a US$100 Million Series C Financing News provided by Share this article Share this article SHANGHAI, Dec. 17, 2020 /PRNewswire/ dMed, the clinical CRO with strong presence in China and the US, the world s two largest pharmaceutical markets and drug development sites, announced today its successful completion of a US$100 million Series C financing. Led by Fidelity Management & Research Company, LLC, new investors in dMed include Sequoia Capital China, Kaiser Foundation Hospitals and E Fund. They now join the leaders in dMed s angel, A and B rounds, Qiming Venture Partners, Lilly Asia Ventures, and Vivo Capital, which have taken most of the opportunities to increase their contributions to dMed s capital since the company s inception in 2016.

New yorkUnited statesBruxelles capitaleSan franciscoBiopharmaceutical co ltdFidelity management research companyClinical contract research organizationDe fundKaiser foundation hospitalsFidelity managementResearch companySequoia capital chinaQiming venture partnersLilly asia venturesVivo capitalMed founder